Spyre Therapeutics, Inc. (SYRE)
87.09
-1.08
(-1.22%)
USD |
NASDAQ |
Sep 24, 16:00
87.85
+0.76
(+0.87%)
Pre-Market: 08:09
Spyre Therapeutics Gross Profit (Annual) : 0.00 for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| December 31, 2023 | -0.078M |
| December 31, 2022 | 0.365M |
| December 31, 2021 | 16.74M |
| December 31, 2020 | -1.624M |
| Date | Value |
|---|---|
| December 31, 2019 | -0.901M |
| December 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| December 31, 2015 | 5.996M |
| December 31, 2014 | -0.019M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| AbbVie, Inc. | 42.89B |
| Incyte Corp. | 4.703B |
| SELLAS Life Sciences Group, Inc. | 0.00 |
| BridgeBio Pharma, Inc. | 478.38M |
| Relay Therapeutics, Inc. | 11.80M |